Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
CHOP Researchers Develop New Computational Tool to Interpret Clinical Significance of Cancer Mutations
Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a new tool to help researchers interpret […]
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers
InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug […]
Ultomiris Met Primary Endpoint in CHAMPION-NMOSD Phase III Trial in Adults with Neuromyelitis Optica Spectrum Disorder
Positive high-level results from the open-label Phase III CHAMPION-NMOSD trial showed that Ultomiris (ravulizumab-cwvz) achieved a statistically […]
Enhertu Approved in the US for Patients with HER2-positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-based Regimen
AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of […]
National Institute of Health (NIH) Awards Aracari Biosciences a Grant to Further Develop Proprietary Human Bone Marrow Technology That Models in Vivo Drug Responses
Aracari Biosciences, Inc. announces a grant award from the National Institute of Health (NIH) to […]
Curebase Secures $40 Million in Series B Funding
Curebase, a company committed to democratizing access to clinical studies, has raised $40 million in […]
Strong Demand for Lung Intelligence Accelerates VIDA's Growth
VIDA Diagnostics, Inc. (VIDA), the leader in lung and respiratory intelligence, announced it has secured […]
BioWin Spearheads Talent Now, a Unique Initiative to Tackle Recruitment Shortages and Challenges in the Healthtech Industry
BioWin, the health cluster of Wallonia, today announces the launch of `Talent Now’, a new […]
Overjet Partners with Dental Care Alliance, Providing AI to Improve Patient Outcomes
Overjet, a leader in dental artificial intelligence solutions for providers and payers, today announced a […]
Nanoform Launches "STARMAP® Online" Placing AI-power at the Fingertips of Medicine Developers
Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company, today announced that it has launched its […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more